VALNEVA (EPA:VLA) | WebDisclosure

BRIEF

published on 06/04/2025 at 07:05, 9 months 21 days ago

Valneva : Documents pour l'Assemblée Générale et Modification de la Direction

Assemblée Générale Direction Documents Préparatoires Valneva Vaccins
BRIEF

published on 06/04/2025 at 07:05, 9 months 21 days ago

Valneva: Documents for the General Meeting and Change of Management

Direction General Assembly Valneva Preparatory Documents Vaccines
PRESS RELEASE

published on 06/04/2025 at 07:00, 9 months 21 days ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Valneva SE announces availability of documentation for its Combined Shareholder Meeting on June 25, 2025, along with corporate update and executive departure. Details on accessing meeting documents and farewell to Mr. Grimaud

Corporate Update Valneva SE Shareholder Meeting Vaccine Company Franck Grimaud
PRESS RELEASE

published on 06/04/2025 at 07:00, 9 months 21 days ago

Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction
Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction. Assemblée le 25 juin 2025 à Lyon. Consultez le site pour plus d'informations

Annonce Valneva Assemblée Générale Mixte Équipe De Direction Vaccins
BRIEF

published on 05/21/2025 at 13:36, 10 months 4 days ago

Valneva SE: Research Update Reaffirms Buy Rating, Raises Target Price

Target Price Financial Growth Valneva Market Forecast Lyme Vaccine
BRIEF

published on 05/21/2025 at 13:36, 10 months 4 days ago

Valneva SE : une mise à jour de recherche confirme la recommandation d'achat et relève l'objectif de cours

Croissance Financière Valneva Vaccin Contre La Maladie De Lyme Prévisions Du Marché Prix Cible
PRESS RELEASE

published on 05/21/2025 at 13:31, 10 months 4 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research increases price target for Valneva SE to €8.10 following strong Q1/25 results and positive outlook on Lyme disease vaccine candidate, VLA15

First Berlin Equity Research Price Target Valneva SE Lyme Disease Vaccine Q1/25 Results
BRIEF

published on 04/26/2025 at 19:15, 10 months 29 days ago

Partial suspension of the use of Valneva's IXCHIQ® vaccine

Security Valneva France Vaccine Chikungunya
BRIEF

published on 04/26/2025 at 19:15, 10 months 29 days ago

Suspension partielle de l'utilisation du vaccin IXCHIQ® de Valneva

Sécurité Valneva France Vaccin Chikungunya
PRESS RELEASE

published on 04/26/2025 at 19:10, 10 months 29 days ago

Valneva fait un point sur la recommandation d’utilisation de son vaccin contre le chikungunya par les autorités françaises
Valneva met à jour la recommandation d'utilisation de son vaccin IXCHIQ® contre le chikungunya en France suite à des effets indésirables chez les personnes âgées avec comorbidités. Valneva collabore avec les autorités pour assurer la sécurité

Valneva Vaccin Chikungunya Autorités Sanitaires Effets Indésirables

Published on 03/25/2026 at 19:15, 1 hour 27 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 7 hours 12 minutes ago

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 7 hours 12 minutes ago

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 13:30, 7 hours 12 minutes ago

Strategic Metals Closes Project Sale
Published on 03/25/2026 at 13:25, 7 hours 17 minutes ago

Predictiv AI Expands Active Deployment of CloudRep.ai Across Healthcare, Retail, Real Estate, Travel and Global Markets

View all ACCESSWIRE

Published on 03/25/2026 at 20:00, 42 minutes ago

Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 1 hour 1 minute ago

EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 1 hour 12 minutes ago

AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 1 hour 16 minutes ago

EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:40, 2 hours 2 minutes ago

TULKUBASH AND KYZYLTASH MINING ASSETS: DECLARATION FROM A GROUP OF INVESTORS

View all EQS

Published on 03/25/2026 at 18:53, 1 hour 49 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:53, 1 hour 49 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 2 hours 11 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 18:31, 2 hours 11 minutes ago

Performance soutenue des Investissements et déploiement actif de la stratégie
Published on 03/25/2026 at 18:06, 2 hours 36 minutes ago

LNA SANTE : Résultats Annuels 2025

View all LES ECHOS COMFI WIRE

News